Clinical Trials on Cancer in South Africa
Total 3155 results
-
Eli Lilly and CompanyActive, not recruitingProstate CancerUnited States, China, Australia, Japan, Spain, Korea, Republic of, Netherlands, Denmark, Germany, France, Romania
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)TerminatedLung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Large Cell Lung Carcinoma | Bronchioloalveolar Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Taiwan, Portugal, France, Italy, Australia, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Completed
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular Carcinoma | Liver CancerUnited States, Canada, Germany, France, Russian Federation, Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Hong Kong, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Puerto Rico, Romania, Sing... and more
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingAtypical Endometrial Hyperplasia | Human Papillomavirus Infection | Stage 0 Cervical Cancer AJCC v7United States, Korea, Republic of, Japan
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedPain | Esophagitis | Lung Cancer | DysphagiaUnited States
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Korea, Republic of, Taiwan, Thailand, France, Turkey, Italy, Switzerland, Brazil, Singapore, Germany, Chile, Norway
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBrain CancerUnited States, Canada, Belgium, Spain, Australia, Netherlands, United Kingdom, Denmark, Norway, Japan, Sweden, France, Poland, Austria, Germany, Israel, Italy, Russian Federation, Switzerland
-
CelgeneCompletedSquamous Cell Carcinoma, Non-Small-Cell LungUnited States, Spain, Germany, Italy, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | NeurotoxicityUnited States
-
National Cancer Institute (NCI)CompletedRefractory Differentiated Thyroid Gland Carcinoma | Unresectable Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaUnited States, Canada
-
Hoffmann-La RocheCompletedSmall Cell Lung CarcinomaKorea, Republic of, United States, Hungary, Poland, China, France, Greece, Spain, United Kingdom, Brazil, Italy, Germany, Mexico, Australia, Serbia, Russian Federation, Japan, Austria, Chile, Czechia, Taiwan
-
Gilead SciencesTerminatedColorectal CancerSpain, United States, Germany, Italy, Russian Federation, Poland, France
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States
-
PfizerTerminatedCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Carcinoma, Large Cell | Carcinoma, Adenosquamous CellUnited States, Bulgaria, Italy, Spain, Ukraine, Belgium, France, Ireland, Korea, Republic of, Poland, Russian Federation, United Kingdom, Hungary, Serbia, Taiwan, Canada, South Africa, Brazil, Romania, Greece, Puerto Rico, Czech Republic and more
-
PfizerCompletedKidney NeoplasmsKorea, Republic of, United States, Canada, Spain, Italy, United Kingdom, China, Singapore, Slovakia, France, Japan, Australia, Germany, Taiwan, Brazil, Russian Federation, India, Poland, Austria, Greece, Ireland, Sweden
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMetastatic Cancer | Melanoma (Skin)United States
-
Monopar TherapeuticsTerminatedChemoradiotherapy-Induced Severe Oral MucositisUnited States, Spain, Germany, France, Puerto Rico
-
Eisai Inc.CompletedEndometrial CancerUnited States, Poland, Ukraine, Bulgaria, Romania, Belgium, Russian Federation, Hungary
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingSkin Squamous Cell Carcinoma | Metastatic Skin CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | TFE3-Rearranged Renal Cell CarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingTongue Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage IVB Oropharyngeal Squamous Cell Carcinoma | Stage IVC Oropharyngeal Squamous Cell Carcinoma | Stage III Oropharyngeal Squamous Cell CarcinomaUnited States, Canada, Saudi Arabia, Ireland
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaUnited States, Poland, Israel, Argentina, Australia, Austria, Canada, China, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, Portugal, Romania, Spain, Turkey, United...
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingCervical CancerUnited States, Korea, Republic of, Hong Kong, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingBreast Cancer | Cognitive ImpairmentsUnited States
-
Merck Sharp & Dohme LLCRecruitingColorectal CancerUnited States, Belgium, Canada, Germany, Italy, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, United Kingdom, France, Denmark, Romania, Estonia, Hungary, Guatemala, Costa Rica, Lithuania, Greece, Colombia, Netherl...
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedFatigue | Anemia | Prostate CancerUnited States
-
Merck Sharp & Dohme LLCGOG Foundation; European Network for Gynaecological Oncological Trial groups(ENGOT)RecruitingEndometrial CancerPoland, Canada, Australia, Israel, Korea, Republic of, United States, Spain, Chile, France, Puerto Rico, Greece, Netherlands, Norway, Singapore, Switzerland, Argentina, Austria, Belgium, Czechia, Denmark, Finland, Malaysia, Sweden, Italy and more
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
GTxCompletedProstate Cancer | Osteoporosis | FracturesUnited States, Mexico
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid AdenocarcinomaUnited States, Canada